ImVitro

ImVitro is a Paris-based deeptech company founded in 2019 that specializes in enhancing the in-vitro fertilization (IVF) process through advanced software solutions. The company leverages artificial intelligence and computer vision technologies to develop its core product, the EMBRYOLY platform. This B2B SaaS platform automates embryo evaluation by analyzing fertility imaging data, drawing from a vast dataset that represents over 50 years of embryology expertise. The EMBRYOLY platform aims to improve IVF success rates by refining embryo selection, reducing failed embryo transfers, and enhancing quality control within the IVF workflow. It is currently utilized by more than 10 clinics in France and Spain, with plans for expansion into the U.S. market. ImVitro's mission is to facilitate a smoother path to parenthood by providing IVF clinics with tools that optimize decision-making and increase transparency in the IVF process.

• Employees 4
• Founded 2019
• Annual Revenue $2400000
• Total Funding $2500000